Do Wall Street Analysts Like IDEXX Laboratories Stock?

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) focuses on enhancing the health and well-being of pets, people, and livestock. It develops and distributes products and services for the companion animal veterinary, livestock and poultry, water testing and dairy markets. With a market cap of $37.1 billion, IDEXX operates as a global leader in pet healthcare innovation.

While IDEXX has notably underperformed the broader market over the past year, it has significantly outperformed in 2025. IDEXX stock has plummeted 19.5% over the past year and soared 12.2% on a YTD basis, compared to the S&P 500 Index’s ($SPX) 17.6% returns over the past year and 1.7% gains in 2025.